Ballantyne Strong is a holding company. Through its subsidiaries, the company is focused on serving the cinema, retail, financial, advertising and government markets. The company conducts its operations through three operating segments: Strong Cinema, which provides projection screens, technical support services and other related products to the cinema exhibition industry; Convergent, which delivers digital signage solutions and services to various enterprise markets, including retail, banking and healthcare, as well as certain government agencies and Digital-Out-Of-Home advertising network operators; and Strong Outdoor, which provides advertising services and experiential marketing services.

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

Discover Financial Services is a bank holding, as well as a financial holding company. The company manages its business activities in two segments: Direct Banking, which includes consumer banking and lending products, specifically Discover-branded credit cards issued to individuals on the Discover Network and other consumer banking products and services, including student loans, personal loans, home equity loans, and deposit products; and Payment Services, which includes the PULSE network, Diners Club International and its Network Partners business, which provides payment transaction processing and settlement services on the Discover Network.

Esperion Therapeutics is a pharmaceutical company that develops and commercializes oral, once-daily, non-statin medicines for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). The company's primary products, NEXLETOL? tablet and NEXLIZET? tablets, are oral, once-daily, non-statin LDL-C lowering medicines approved in the U.S. for patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH). The U.S. Food and Drug Administration has approved NEXLETOL as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with HeFH or established ASCVD who require additional lowering of LDL-C.

Everspin Technologies is a provider of magnetoresistive random access memory (MRAM) solutions. The company's portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), is delivering persistence non-volatile memories that transform how mission-critical data is protected against power loss. The company's MRAM solutions allow its customers in the industrial, automotive and transportation, and enterprise storage markets to design systems without the need for batteries or capacitors. The company's MRAM solutions as well as other offerings include: Toggle MRAM; Spin-Transfer Torque MRAM; and Tunnel Magneto Resistance Sensors.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

PBF Energy is a holding company. Through its subsidiaries, the company is engaged as an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants and other petroleum products in the U.S. The company operates in two business segments: refining, which the company produces a variety of products at each of its refineries such as gasoline, ultra-low-sulfur diesel, heating oil, jet fuel, lubricants, petrochemicals and asphalt; and logistics, which through its PBF Logistics LP subsidiary, the company owns or leases, operates, develops and acquires crude oil and refined petroleum products terminals, pipelines, storage facilities and similar logistics assets.

Safehold is a holding company. Through its subsidiaries, the company operates its business through one segment by acquiring, managing and capitalizing ground leases. Ground leases generally represent the ownership of land underlying commercial real estate properties, which are leased on a long-term basis (base terms are 30 to 99 years, often with tenant renewal options) by the land owner to a tenant that owns and operates the building on top of the land, or what the company refer to as a Safehold?.

Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is engaged in the field of semaphorin 4D (SEMA4D) biology, targeting SEMA4D as a potential treatment for cancer, neurodegenerative diseases, or autoimmune disorders. The company is utilizing its SEMA4D antibody platform to develop its primary product candidate, pepinemab (VX15/2503), an antibody that utilizes mechanisms of action. The company is focused on the development of pepinemab for the treatment of non-small cell lung cancer, Huntington's disease, and Alzheimer's disease.